
Patients remember how you respond to adverse pregnancy outcomes such as stillbirth and fetal loss.

Patients remember how you respond to adverse pregnancy outcomes such as stillbirth and fetal loss.

For Contemporary OB/GYN, Dr Bobby Lazzara looks at the recent spindle nuclear transfer performed in Mexico which resulted in a child, the first one created with genetic material from 3 adults, and examines the possible implications.

Researchers looked at time to catheter expulsion and time to delivery.

A study in Israel compared mothers older and younger than 35.

A look at the frameworks for decision-making regarding reproductive choice and prenatal testing.

Changes to practice guidelines and insurance coverage are needed, the authors say.

A study examines the safety of MRI scans during pregnancy. Plus: Researchers at Florida State University identify several compound that could combat Zika.

Relative risk of stillbirth and preterm birth associated with less well-known antibodies was of similar magnitude to that found for anti-D.

On L&D units throughout the country, more and more women are being admitted with birth plans. Birth plans have become an increasingly common part of women’s prenatal preparation.

An expert commentary on Practice Bulletin No. 156: Obesity in Pregnancy.

“Women have very polarized views about induction... some are keen to be induced near their due date ... Others, however, feel that nature knows best and induction is meddlesome."

Dutch researchers reviewed data from 62,000 Rh-negative women to determine how to best detect and treat severe hemolytic disease of the fetus and newborn.

An interview with the doctor behind the near-elimination of US deaths due to Rh disease.

A better understanding of the care and outcomes of women with severe morbidity who survive should provide insight into ways to improve care for all women and reduce both severe morbidity and mortality.

In Florida, the public is worried and the news keeps getting worse.

A study in Tehran tested this noninvasive intervention on women with uncomplicated pregnancies at full term.

For Contemporary OB/GYN, Dr Bobby Lazzara discusses key findings of a study published in Science Translational Medicine. The study looked at how delivery mode impacted the gut microbiome of infants and wondered about the long-term impact.

Pregnant women are worried, and their concern is warranted. Here is what we know now and what’s being done about this health crisis.

Clinicians should be aware of the potential for confounding of NIPT results by cfDNA released from a vanishing twin.

Antenatal anti-D immunoglobulin helps reduce the incidence of RhD alloimmunization in Rh-negative women, but should it be administered to non-sensitized women prophylactically?

Seven strategies to fight the rising tide.

A study in Sweden looked at safety and effectiveness.

A study looked at the outcomes for women who had prolonged premature rupture of membranes at term.

Research supports moving from routine antenatal anti-Rhesus D (RhD) prophylaxis in unsensitized RhD-negative pregnant women to a targeted approach.

A study found that IV drug abusing pregnant women had a two-fold higher relative risk of alloimmunization.